IL-8 is a novel prometastatic chemokine in intrahepatic cholangiocarcinoma that induces CXCR2-PI3K/AKT signaling upon CD97 activation

Abstract Intrahepatic cholangiocarcinoma (ICC) is a rare but highly aggressive malignant tumor arising within the liver, with a 5-year survival rate of only 20–40% after surgery. The role of interleukin-8 (IL-8) in ICC progression remains elusive. A transcriptomic approach based on IL-8 stimulation...

Full description

Bibliographic Details
Published in:Scientific Reports
Main Authors: Ze-Wu Meng, Lei Zhang, Xin-Ran Cai, Xing Wang, Fei-Fei She, Yan-Ling Chen
Format: Article
Language:English
Published: Nature Portfolio 2023-10-01
Online Access:https://doi.org/10.1038/s41598-023-45496-3